BioWorld 2025年12月3日

智盟生物医药描述治疗乙肝感染新化合物

BioWorld - Friday, December 26, 2025 To read the full story, subscribe or sign in. Infection Zhimeng Biopharma describes new compounds to treat HBV infection Dec. 3, 2025 Zhimeng Biopharma has identified compounds reported to be useful for the treatment of hepatitis B viral (HBV) infection. BioWorld ScienceInfectionPatents